Barclays’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8M | Sell |
185,424
-27,074
| -13% | -$3.63M | 0.01% | 729 |
|
|
2025
Q1 | $14.3M | Sell |
212,498
-13,905
| -6% | -$935K | ﹤0.01% | 852 |
|
|
2024
Q4 | $14.1M | Buy |
226,403
+35,603
| +19% | +$2.22M | ﹤0.01% | 910 |
|
|
2024
Q3 | $30M | Buy |
190,800
+84,858
| +80% | +$13.3M | 0.01% | 627 |
|
|
2024
Q2 | $16M | Sell |
105,942
-91,649
| -46% | -$13.8M | ﹤0.01% | 763 |
|
|
2024
Q1 | $14.6M | Sell |
197,591
-8,490
| -4% | -$628K | 0.01% | 852 |
|
|
2023
Q4 | $16.3M | Buy |
206,081
+23,472
| +13% | +$1.85M | 0.01% | 804 |
|
|
2023
Q3 | $10M | Buy |
182,609
+31,092
| +21% | +$1.7M | 0.01% | 865 |
|
|
2023
Q2 | $12.7M | Buy |
151,517
+135,977
| +875% | +$11.4M | 0.01% | 825 |
|
|
2023
Q1 | $1.18M | Buy |
15,540
+7,346
| +90% | +$556K | ﹤0.01% | 2014 |
|
|
2022
Q4 | $506K | Buy |
8,194
+6,900
| +533% | +$426K | ﹤0.01% | 2592 |
|
|
2022
Q3 | $54K | Sell |
1,294
-56
| -4% | -$2.34K | ﹤0.01% | 3634 |
|
|
2022
Q2 | $42K | Sell |
1,350
-2,972
| -69% | -$92.5K | ﹤0.01% | 3795 |
|
|
2022
Q1 | $116K | Sell |
4,322
-27,137
| -86% | -$728K | ﹤0.01% | 3602 |
|
|
2021
Q4 | $603K | Buy |
31,459
+20,866
| +197% | +$400K | ﹤0.01% | 2453 |
|
|
2021
Q3 | $350K | Buy |
10,593
+7,260
| +218% | +$240K | ﹤0.01% | 2750 |
|
|
2021
Q2 | $110K | Sell |
3,333
-17,686
| -84% | -$584K | ﹤0.01% | 3109 |
|
|
2021
Q1 | $872K | Buy |
21,019
+11,482
| +120% | +$476K | ﹤0.01% | 2375 |
|
|
2020
Q4 | $189K | Sell |
9,537
-1,963
| -17% | -$38.9K | ﹤0.01% | 2721 |
|
|
2020
Q3 | $158K | Sell |
11,500
-866
| -7% | -$11.9K | ﹤0.01% | 2848 |
|
|
2020
Q2 | $223K | Buy |
12,366
+7,634
| +161% | +$138K | ﹤0.01% | 2753 |
|
|
2020
Q1 | $57K | Sell |
4,732
-9,511
| -67% | -$115K | ﹤0.01% | 3044 |
|
|
2019
Q4 | $271K | Buy |
14,243
+10,980
| +337% | +$209K | ﹤0.01% | 3030 |
|
|
2019
Q3 | $77K | Sell |
3,263
-6,825
| -68% | -$161K | ﹤0.01% | 3525 |
|
|
2019
Q2 | $292K | Buy |
+10,088
| New | +$292K | ﹤0.01% | 2996 |
|